Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its more than 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com. Please see below for global employment opportunities: Daiichi Sankyo Europe: http://linkd.in/1C7vu7Z Daiichi Sankyo Inc: http://linkd.in/1aDztT4 Daiichi Sankyo Spain: http://linkd.in/1DUavKt Daiichi Sankyo Germany: http://linkd.in/1GZA11G Daiichi Sankyo UK: http://linkd.in/1FwcGTo Daiichi Sankyo Switzerland: http://linkd.in/1GZA3GR Daiichi Sankyo France: http://linkd.in/1yPOAhu Daiichi Sankyo Brazil: http://linkd.in/1CMnnQO Daiichi Sankyo Ireland: http://linkd.in/1GZAbX2